These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7589887)

  • 1. The pathogenesis of NIDDM: the role of the pancreatic beta cell.
    Zawalich WS; Kelley GG
    Diabetologia; 1995 Aug; 38(8):986-91. PubMed ID: 7589887
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.
    Unger RH
    Diabetes; 1995 Aug; 44(8):863-70. PubMed ID: 7621989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion in obese and non-obese NIDDM.
    Cerasi E; Nesher R; Gadot M; Gross D; Kaiser N
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S27-37. PubMed ID: 8529516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity.
    Ueda H; Ikegami H; Yamato E; Fu J; Fukuda M; Shen G; Kawaguchi Y; Takekawa K; Fujioka Y; Fujisawa T
    Diabetologia; 1995 May; 38(5):503-8. PubMed ID: 7489831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats.
    Tang J; Pugh W; Polonsky KS; Zhang H
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E504-12. PubMed ID: 8638699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes.
    Johnson JH; Ogawa A; Chen L; Orci L; Newgard CB; Alam T; Unger RH
    Science; 1990 Oct; 250(4980):546-9. PubMed ID: 2237405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-cell GLUT-2 loss and non-insulin-dependent diabetes mellitus: current status of the hypothesis.
    Milburn JL; Ohneda M; Johnson JH; Unger RH
    Diabetes Metab Rev; 1993 Oct; 9(3):231-6. PubMed ID: 8187609
    [No Abstract]   [Full Text] [Related]  

  • 8. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
    Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
    Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats.
    Zawalich WS; Zawalich KC
    Endocrinology; 2000 Sep; 141(9):3287-95. PubMed ID: 10965900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
    Polonsky KS
    Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?
    Cerasi E
    Diabetologia; 1995 Aug; 38(8):992-7. PubMed ID: 7589888
    [No Abstract]   [Full Text] [Related]  

  • 13. Preservation of insulin release periodicity from individual islets of obese Zucker rats.
    Hayek A
    Horm Metab Res; 1981 Feb; 13(2):119-20. PubMed ID: 7014407
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
    Evans AJ; Krentz AJ
    Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
    [No Abstract]   [Full Text] [Related]  

  • 15. NIDDM is associated with loss of pancreatic beta-cell L-type Ca2+ channel activity.
    Roe MW; Worley JF; Tokuyama Y; Philipson LH; Sturis J; Tang J; Dukes ID; Bell GI; Polonsky KS
    Am J Physiol; 1996 Jan; 270(1 Pt 1):E133-40. PubMed ID: 8772485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.
    Lynn FC; Pamir N; Ng EH; McIntosh CH; Kieffer TJ; Pederson RA
    Diabetes; 2001 May; 50(5):1004-11. PubMed ID: 11334402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet defects and insulin resistance in models of obese non-insulin-dependent diabetes.
    Bailey CJ; Flatt PR
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():43S-50S. PubMed ID: 8299488
    [No Abstract]   [Full Text] [Related]  

  • 18. GLUT2 expression and function in beta-cells of GK rats with NIDDM. Dissociation between reductions in glucose transport and glucose-stimulated insulin secretion.
    Ohneda M; Johnson JH; Inman LR; Chen L; Suzuki K; Goto Y; Alam T; Ravazzola M; Orci L; Unger RH
    Diabetes; 1993 Jul; 42(7):1065-72. PubMed ID: 8513973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity.
    Koyama K; Chen G; Lee Y; Unger RH
    Am J Physiol; 1997 Oct; 273(4):E708-13. PubMed ID: 9357799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagotomy ameliorates islet morphofunction and body metabolic homeostasis in MSG-obese rats.
    Lubaczeuski C; Balbo SL; Ribeiro RA; Vettorazzi JF; Santos-Silva JC; Carneiro EM; Bonfleur ML
    Braz J Med Biol Res; 2015 May; 48(5):447-57. PubMed ID: 25714886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.